tiprankstipranks
Trending News
More News >
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Advertisement

Revance Therapeutics (RVNC) Revenue

Compare
626 Followers

Revance Therapeutics Revenue

Revance Therapeutics had a revenue of 59.88M in the quarter ending Sep 30, 2024, with -8.43%. This bring the company's revenue in the last twelve months to 247.00M, Decreased 1.27%. In the fiscal year ending Dec 31, 2023, Revance Therapeutics had annual revenue of 234.04M with 76.55% growth.
Revenue (ttm)
247.00M
Revenue Growth
15.33%
P/S Ratio
1.63
Revenue/Employee
$392,027
Employees
597
Market Cap
$381.02M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
234.04M101.47M+76.55%
Dec 31, 2022
132.56M54.77M+70.40%
Dec 31, 2021
77.80M62.47M+407.65%
Dec 31, 2020
15.32M14.91M+3,610.65%
Dec 31, 2019
413.00K-3.32M-88.92%
Dec 31, 2018
3.73M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis